Patents for A61P 35 - Antineoplastic agents (221,099)
07/1991
07/03/1991EP0434727A1 Red-shifted phthalocyanine and tetrabenztriazaporphyrin reagents
07/03/1991EP0434722A1 New pentapeptide and a process for the preparation thereof
07/03/1991EP0434718A1 Peptide compounds
07/03/1991EP0425507A4 Compositions and methods for treating skin conditions and promoting wound healing
07/03/1991EP0398925A4 Growth inhibiting agent and the use thereof
07/03/1991CN1052678A 2,19-methyleneoxy and 2,19-methylenethio bridged steroids as aromatase and 19-hydroxylase inhibitors
07/03/1991CN1052659A Fluoro-naphthacenediones, their glycosilated derivatives and their manufacture procedures
07/02/1991US5028727 Platinum-(IV)-diamine complex
07/02/1991US5028698 Cytorhodin S derivatives and a process for their preparation
07/02/1991US5028697 Antitumor agents, cell specific
07/02/1991US5028626 Peptides with pharmaceutical activity
07/02/1991US5028621 Drugs comprising porphyrins
07/02/1991US5028593 Tuftsin analogs
07/02/1991US5028536 Antitumor antibiotic BMY-41339
07/02/1991US5028420 Muteins of tumor necrosis factor
07/02/1991CA1285562C Quinone derivatives, their production and use
07/02/1991CA1285560C Derivatives of guanine
07/02/1991CA1285507C Hybrid interferons
07/02/1991CA1285479C Immunostimulant agents
06/1991
06/29/1991WO1991009875A1 Monoclonal antibody, hybridomas, their production and use
06/29/1991CA2069872A1 Monoclonal antibody, hybridomas, their production and use
06/28/1991CA2032974A1 Process for the preparation of glycosylanthracyclinones
06/28/1991CA2032972A1 Benzanthracene compound and a process for preparing the same
06/27/1991WO1991009124A1 Variants of pai-2
06/27/1991WO1991009057A1 Novel proteins with oncostatin m activity and process for their preparation
06/27/1991WO1991009046A1 Morpholinyl derivatives of doxorubicin and process for their preparation
06/27/1991WO1991008770A1 Method for antibody targeting of diagnostic or therapeutic agents
06/27/1991WO1991008743A1 Circumvention of human tumor drug resistance
06/27/1991DE3942280A1 N-substituierte naphthalimide, ihre herstellung und verwendung N-substituted naphthalimides, their preparation and use
06/27/1991CA2070171A1 Proteins with oncostatin m activity and process for their preparation
06/27/1991CA2045601A1 Circumvention of human tumor drug resistance
06/26/1991WO1991009612A1 Tumor cell growth inhibitor
06/26/1991EP0434571A2 New steroid derivatives with a substituted ethyl group on the position 10, process for their production, the use as a medicine of one of these compounds and pharmaceutical compositions containing it.
06/26/1991EP0434445A2 Process to obtain new mixed copper aminoacidate complexes from phenanthrolines and their alkyl derivatives to be used as anticancerigenic agents
06/26/1991EP0434444A1 Process to obtain new mixed copper aminoacidate complexes from phenylate Phenathrolines to be used as anticancerigenic agents
06/26/1991EP0434057A2 Indolocarbazole derivatives, processes for their preparation and their use
06/26/1991EP0434020A1 2,19-Methyleneoxy and 2,19-methylenethio bridged steroids as aromatase and 19-hydroxylase inhibitors
06/26/1991EP0433827A2 Cytotoxic lymphocyte maturation factor and monoclonal antibodies directed thereto
06/26/1991EP0433765A1 The use of immunomodulants as synergistic agents of chemotherapeutics in tumor therapy
06/26/1991EP0433744A1 Semisynthetic derivatives with immunomodulation activity, suitable for parenteral and oral administration
06/26/1991EP0433683A2 Use of benzothiazepines as potentiators of anti-cancer drugs
06/26/1991EP0433682A2 Use of 2,4,5-tri(4-methoxyphenyl)-4,5-dihydroimidazole for the treatment of cancer
06/26/1991EP0433678A1 Alkoxymethylidene epipodophyllotoxin glucosides
06/26/1991EP0433442A1 Hybrid molecules
06/26/1991EP0433360A1 Improvements relating to the production of prodrugs.
06/26/1991CN1012957B Process for preparation of quinoline derivatives
06/26/1991CA2044621A1 Inhibiting agent against the proliferation of tumour cells
06/25/1991US5026882 Phosphinic acid substituted steroids as inhibitors of steroid 5α-reductase
06/25/1991US5026836 6-sulfenamide, 6-sulfinamide and 6-sulfonamide purines, purine nucleosides, purine nucleotides, pharmaceutical compositions, and processes of making
06/25/1991US5026826 Human neutrophilic granulocyte end-stage maturation factor and its preparation and use
06/25/1991CA1285287C Cycloalkyl-substituted-4-aminophenyl derivatives and process for their preparation
06/23/1991CA2572802A1 Cytotoxic lymphocyte maturation factor and monoclonal antibodies directed thereto
06/22/1991WO1991009965A1 An improved toxin for construction of immunotoxins
06/22/1991WO1991009850A1 N-substituted naphthalamides, their production and use
06/22/1991CA2071946A1 Toxin for construction of immunotoxins
06/22/1991CA2066457A1 N-substituted naphthalimides, their preparation and use
06/21/1991WO1991009048A1 Boronated nucleosides
06/21/1991WO1991009033A1 Uncharged morpholino-based polymers having phosphorous-containing chiral intersubunit linkages
06/21/1991CA2071936A1 Boronated nucleosides
06/19/1991EP0433225A1 Process for the production of biologically active protein (e.g. TGF)
06/19/1991EP0432983A2 Novel compounds of the diterpene type
06/19/1991EP0432697A2 BU-4146T antibiotic
06/19/1991EP0432677A1 N-(pyrrolo[2,3-d]pyrimidin-3-ylacyl)-glutamic acid derivatives
06/19/1991EP0432630A2 Antitumor agent
06/19/1991EP0432209A1 Phenylpyrrolic compounds used as drugs, their preparation and application.
06/19/1991EP0248047B1 Medicament with anti-tumoral action containing hexadecylphosphocholine
06/18/1991US5024835 Conjugates of a vinca derivative carrying a detergent chain in the C-3 position
06/16/1991CA2032212A1 Compounds of the diterpene type
06/15/1991CA2031394A1 Semisynthetic derivatives with immunomodulation activity, suitable for parenteral and oral administration
06/14/1991WO1991008739A1 Growth arrest of proliferating cells by transglutaminase inhibitors
06/14/1991CA2071550A1 Growth arrest of proliferating cells by transglutaminase inhibitors
06/14/1991CA2032092A1 Antitumor agent
06/13/1991WO1991008215A1 Process for the preparation of 2-amino-9-(2,3,5-tri-0-benzyl-beta-d-arabinofuranosyl)adenine and novel intermediates
06/13/1991WO1991008214A1 Dna segment encoding a gene for a receptor related to the epidermal growth factor receptor
06/13/1991WO1991008191A1 Novel potent inducers of terminal differentiation and method of use thereof
06/13/1991WO1991007953A1 Tumour necrosis factor antagonist
06/13/1991WO1991002062A3 C-erbb-2 external domain: gp75
06/12/1991EP0431799A2 Use of nucleoside derivatives as cytotoxic agents
06/12/1991EP0431323A1 Antitumor antibiotic BU-3983T
06/12/1991EP0431008A1 Mitomycin derivatives having reduced bone marrow toxicity, processes for their preparation, and the uses thereof
06/12/1991CN1012815B Process for preparing gem-dihalo and tetrahalo-1,12-diamino-4,9-diaza-dodecanes
06/12/1991CA2031650A1 Bu-4146t antibiotic
06/11/1991US5023341 Acetylene thiochroman
06/11/1991US5023340 Glycosidase inhibitors
06/11/1991US5023335 1,2-bis (aminomethyl) cyclobutane-platinum complexes
06/11/1991US5023254 Administering antiestrogens
06/11/1991US5023184 Antibiotics from myxococcus
06/06/1991DE3939372A1 Mitonafide-infusionsloesung Mitonafide-infusion spoon
06/05/1991EP0430538A1 Isolation and structural elucidation of the cyclic peptide hymenistatin 1
06/05/1991EP0430193A1 Monoclonal antibodies and their use
06/05/1991EP0430036A2 Benzothiazepine metastasis treatment
06/05/1991EP0429585A1 Cytochalasin compositions and therapeutic methods
06/05/1991EP0429454A1 Improvements relating to the control of neoplastic tissue growth
06/05/1991CN1051937A Stem cell factor
06/05/1991CN1051914A Peptides
06/05/1991CN1051907A 24-homo-vitamin-0-derivatives, process for preparing them, pharmaceutical preparation containing them and use as pharmaceuticals
06/05/1991CN1012732B Gen-dihalo-1, 8-diamino-4-aza-octanes
06/04/1991US5021434 N-substituted imidazoles, as well as their use in pharmaceutical agents
06/04/1991US5021423 Antibiotic, antitumor agent
06/04/1991US5021235 Reducing and complexing radioactive perrhenates with bone seeking ligands